ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L01XX" (54)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Asparaginase (L01XX02) 1 products WHO-DDD DrugBank.ca 
  IP  Enrylaze 10 mg/vial3k.A.Injection solution: Crisantaspasum 10mg / 0.5mlMEDA Pharmaceuticals
Switzerland GmbH		AG
Hydroxycarbamide (L01XX05) 6 products WHO-DDD DrugBank.ca 
  IPCI Litalir100 Capsule(s)65.3887.1510 %Capsules: Hydroxycarbamidum 500 mgCheplapharm Schweiz
GmbH		A / SL / SOG
  IPCI Hydroxycarbamid Devatis 500 mg10059.4481.0510 %Capsules: Hydroxycarbamidum 500 mgDevatis AGA / SL / SGG
  IPCI Hydroxycarbamid Devatis 500 mg10059.4481.0510 %Capsules: Hydroxycarbamidum 500 mgDevatis AGA / SL / SGG
  IPCI Hydroxycarbamid Labatec 500 mg5029.7248.7510 %Capsules: Hydroxycarbamidum 500 mgLabatec Pharma SAA / SL / SGG
  IPCI Hydroxycarbamid Labatec 500 mg10059.4481.0510 %Capsules: Hydroxycarbamidum 500 mgLabatec Pharma SAA / SL / SGG
  IPCI Hydroxycarbamid Labatec 500 mg30k.A.Capsules: Hydroxycarbamidum 500 mgLabatec Pharma SAAG
Topotecan (L01XX17) 5 products WHO-DDD DrugBank.ca 
L IPCI Hycamtin 0.25 mg10 Capsule(s)137.40165.8510 %Capsules: TopotecanumSandoz
Pharmaceuticals AG		● A / SLG
L IPCI Hycamtin 1 mg10 Capsule(s)549.59614.1510 %Capsules: Topotecanum 1 mgSandoz
Pharmaceuticals AG		A / SLG
  IP  Hycamtin 1 mgDurchstechflasche(n)75.7298.30k.A.Lyophilisate: Topotecanum 1 mgSandoz
Pharmaceuticals AG		AG
  IP  Hycamtin 4 mgDurchstechflasche(n)269.88308.25k.A.Lyophilisate: Topotecanum 4 mgSandoz
Pharmaceuticals AG		AG
  IP  Hycamtin 4 mg5 Durchstechflasche(n)1343.741469.55k.A.Lyophilisate: Topotecanum 4 mgSandoz
Pharmaceuticals AG		AG
Irinotecan (L01XX19) 17 products WHO-DDD DrugBank.ca 
  IP  Irinotecan Fresenius 40
mg/2 ml		 37.8357.5510 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2mlFresenius Kabi
(Schweiz) AG		A / SL / SGG
  IP  Irinotecan Fresenius 100
mg/5 ml		 91.81116.2510 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5mlFresenius Kabi
(Schweiz) AG		A / SL / SGG
  IP  Irinotecan Fresenius 300
mg/15 ml		 245.64283.5510 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15mlFresenius Kabi
(Schweiz) AG		A / SL / SGG
  IP  Irinotecan Fresenius 500
mg/25 ml		 368.46416.7010 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25mlFresenius Kabi
(Schweiz) AG		A / SL / SGG
  IP  Irinotecan Labatec 40
mg/2 ml		Durchstechflasche(n)37.8957.6010 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40 mgLabatec Pharma SAA / SL / SGG
  IP  Irinotecan Labatec 100
mg/5 ml		Durchstechflasche(n)91.81116.2510 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100 mgLabatec Pharma SAA / SL / SGG
  IP  Irinotecan Labatec 300
mg/15 ml		Durchstechflasche(n)245.64283.5510 %Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300 mgLabatec Pharma SAA / SL / SGG
  IP  Irinotecan Labatec 500
mg/25 ml		Durchstechflasche(n)k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500 mgLabatec Pharma SAAG
  IP  Irinotecan Orion 40 mg/2 mlDurchstechflasche(n)44.5167.45k.A.Orion Pharma AGAG
  IP  Irinotecan Orion 100 mg/5 mlDurchstechflasche(n)107.87140.25k.A.Orion Pharma AGAG
  IP  Irinotecan Orion 300
mg/15 ml		Durchstechflasche(n)k.A.Orion Pharma AGAG
  IP  Irinotecan Orion 500
mg/25 ml		Durchstechflasche(n)k.A.Orion Pharma AGAG
  IP  Irinotecan Sandoz 40 mg/2 mlDurchstechflasche(n)45.0768.15k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2mlSandoz
Pharmaceuticals AG		AG
  IP  Irinotecan Sandoz 100
mg/5 ml		Durchstechflasche(n)109.22141.80k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5mlSandoz
Pharmaceuticals AG		AG
  IP  Irinotecan Sandoz 150
mg/7.5 ml		Durchstechflasche(n)158.91198.85k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 150mg / 7.5mlSandoz
Pharmaceuticals AG		AG
  IP  Irinotecan Sandoz 300
mg/15 ml		Durchstechflasche(n)294.88354.90k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15mlSandoz
Pharmaceuticals AG		AG
  IP  Irinotecan Sandoz 500
mg/25 ml		Durchstechflasche(n)k.A.Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25mlSandoz
Pharmaceuticals AG		AG
Mitotane (L01XX23) 1 products WHO-DDD DrugBank.ca 
  IPCI Lysodren100 Tablet(s)k.A.Tablets: Mitotanum 500 mgEffRx Pharmaceuticals SAAG
Pegaspargase (L01XX24) 1 products WHO-DDD DrugBank.ca 
L IP  Oncaspar 750 UI/ml 1608.081765.3010 %poudre pour solution injectable: Pegaspargasum 3750 UIServier (Suisse) SAA / SLG
Arsenic Trioxide (L01XX27) 1 products WHO-DDD DrugBank.ca 
L IP  Trisenox 12 mg/6 ml103157.853450.7510 %Concentrate for infusion: Arsenii Trioxidum 12mg / 6mlTeva Pharma AGA / SLG
Anagrelide (L01XX35) 4 products WHO-DDD DrugBank.ca 
  IPCI Thromboreductin 0.5 mg100 Capsule(s)198.18230.7510 %Capsules: AnagrelidumOrPha Swiss GmbHB / SL / SOG
  IPCI Xagrid 0,5 mg100 Capsule(s)207.67240.4510 %Capsules: AnagrelidumTakeda Pharma AGB / SLG
  IPCI Thromboreductin 0.5 mg42 Capsule(s)94.59119.7010 %Capsules: AnagrelidumOrPha Swiss GmbHB / SL / SOG
  IPCI Thromboreductin 1 mg100 Capsule(s)325.02367.9010 %Capsules: Anagrelidum 1 mgOrPha Swiss GmbHB / SL / SOG
Eribulin (L01XX41) 2 products WHO-DDD DrugBank.ca 
L IP  HalavenDurchstechflasche(n)188.66221.6010 %Injection solution: Eribulini Mesilas 1 mgEisai Pharma AGA / SLG
     Eribulin Advanz Pharma
0.44 mg/ml		 k.A.Injection solution: EribulinumAdvanz Pharma
Specialty Medicine
Switzerland GmbH		AG
Aflibercept (L01XX44) 2 products WHO-DDD DrugBank.ca 
L IP  Zaltrap 100 mg/4 mlDurchstechflasche(n)388.94439.4010 %concentré pour solution pour perfusion: Afliberceptum 100mg / 4mlSanofi-Aventis
(Suisse) SA		A / SLG
L IP  Zaltrap 200 mg/8 mlDurchstechflasche(n)777.87862.4010 %concentré pour solution pour perfusion: Afliberceptum 200mg / 8mlSanofi-Aventis
(Suisse) SA		A / SLG
Venetoclax (L01XX52) 7 products WHO-DDD DrugBank.ca 
L IPCIPPVenclyxto 10 mg1457.4978.9510 %Coated tablets: Venetoclaxum 10 mgAbbVie AGA / SLG
L IPCIPPVenclyxto 50 mg7143.73172.7510 %Coated tablets: Venetoclaxum 50 mgAbbVie AGA / SLG
L IPCIPPVenclyxto 100 mg7287.46329.0510 %Coated tablets: Venetoclaxum 100 mgAbbVie AGA / SLG
L IPCIPPVenclyxto 100 mg14574.92641.7010 %Coated tablets: Venetoclaxum 100 mgAbbVie AGA / SLG
L IPCIPPVenclyxto 100 mg1124599.395018.5510 %Coated tablets: Venetoclaxum 100 mgAbbVie AGA / SLG
  IPCIPPVenclyxto 10 mg10k.A.Coated tablets: Venetoclaxum 10 mgAbbVie AGAG
  IPCIPPVenclyxto 50 mg5k.A.Coated tablets: Venetoclaxum 50 mgAbbVie AGAG
Selinexor (L01XX66) 5 products WHO-DDD  
L IPCI Nexpovio 20 mg165300.555746.1510 %Coated tablets: Selinexorum 20 mgStemline Therapeutics
Switzerland GmbH		A / SLG
  IPCI Nexpovio 20 mg8k.A.Coated tablets: Selinexorum 20 mgStemline Therapeutics
Switzerland GmbH		AG
  IPCI Nexpovio 20 mg12k.A.Coated tablets: Selinexorum 20 mgStemline Therapeutics
Switzerland GmbH		AG
  IPCI Nexpovio 20 mg20k.A.Coated tablets: Selinexorum 20 mgStemline Therapeutics
Switzerland GmbH		AG
  IPCI Nexpovio 20 mg32k.A.Coated tablets: Selinexorum 20 mgStemline Therapeutics
Switzerland GmbH		AG
Tagraxofusp (L01XX67) 1 products WHO-DDD  
L IP  Elzonris 1mg / ml 16243.5016973.6510 %Concentrate for infusion: Tagraxofuspum 1 mg/mlStemline Therapeutics
Switzerland GmbH		A / SLG
Lurbinectedin (L01XX69) 1 products WHO-DDD  
L IP  Zepzelca 4 mg + + 5343.755790.5010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Lurbinectedinum 4 mgPharmaMar AGA / SLG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home